文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

撒哈拉以南非洲严重HIV相关结核病的蛋白质组免疫特征:乌干达前瞻性多中心分析

Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda.
PubMed 文献 · Crit Care Explor · 2026-08-27
一句话结论在乌干达住院的严重发热成人中,HIV合并微生物学确诊结核者病死率最高,8蛋白特征可区分该表型。

该研究分析乌干达两个前瞻性观察队列(Entebbe发现队列n=241,Tororo验证队列n=253)的蛋白质组数据,纳入年龄≥18岁因严重发热性疾病住院的成人。严重HIV/TB在发现队列占18%、验证队列占21%;合并微生物学确诊TB的PLWH在发现队列30天病死率42%,验证队列60天病死率52%。应用序数随机森林模型在发现队列筛选出8蛋白特征,可区分该表型,涉及巨噬细胞/树突状细胞活化、NK/T细胞刺激与细胞毒作用、B细胞活化、蛋白酶介导组织损伤、凝血失调、细胞外基质重塑及生长激素/IGF轴失调。

要点

  • 合并微生物学确诊TB的PLWH在发现队列30天病死率42%,验证队列60天病死率52%,为最高危表型。
  • 严重HIV/TB在发现队列占18%、验证队列占21%;发现队列30天总病死率22%,验证队列60天总病死率26%。
  • 8蛋白特征可可靠区分PLWH合并微生物学确诊TB表型,涉及巨噬细胞/树突状细胞活化、细胞毒淋巴细胞活化、细胞外基质重塑和凝血失调。
  • 该特征提示宿主导向治疗潜在靶点,但研究为观察性蛋白质组分析,无干预,尚不能用于床旁决策。
  • 研究仅纳入乌干达成人严重发热住院患者,结论外推至其他地区或其他人群需谨慎。

适用人群与场景

  • 乌干达年龄≥18岁因严重发热性疾病住院的成人;发现队列在Entebbe(n=241),验证队列在Tororo(n=253)。

诊断标准与关键阈值

  • HIV/TB表型分层:HIV阴性无TB、PLWH无TB、PLWH合并微生物学确诊TB。
  • 原文未提及严重发热性疾病的具体诊断标准或评分界值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • PLWH合并微生物学确诊TB者最高危:发现队列30天病死率42%,验证队列60天病死率52%。

研究设计与关键结果

  • 研究类型:对两个前瞻性观察队列的蛋白质组数据分析;发现队列n=241(Entebbe),验证队列n=253(Tororo),均为乌干达因严重发热性疾病住院的成人。
  • 严重HIV/TB在发现队列占18%,验证队列占21%;发现队列30天总病死率22%,验证队列60天总病死率26%。
  • PLWH合并微生物学确诊TB者最高危:发现队列30天病死率42%,验证队列60天病死率52%。
  • 在发现队列应用序数随机森林模型筛选出8蛋白特征,可可靠区分PLWH合并微生物学确诊TB表型;涉及巨噬细胞/树突状细胞活化(LAMP3)、NK/T细胞刺激与细胞毒作用(CD70、CRTAM)、B细胞活化(IGLC2)、蛋白酶介导组织损伤(PRSS2/trypsin-2)、凝血失调(SERPINA5)、细胞外基质重塑(EFEMP1)、生长激素/IGF轴失调(IGFBP3)。
  • 原文未提及关键次要终点和不良事件(无干预)。

证据类型、等级与局限

  • 证据类型:前瞻性观察队列的蛋白质组学分析(非RCT)。
  • 局限:观察性设计、无干预、仅乌干达两个中心、样本量有限、蛋白特征需外部验证,原文未提及排除标准。

对床旁实践的改变

  • 该研究提示PLWH合并微生物学确诊TB是最高危表型(发现队列30天病死率42%,验证队列60天病死率52%),但为观察性蛋白质组分析,尚不能改变急诊/ICU的筛查或治疗决策。
  • 8蛋白特征目前仅用于研究,不能作为床旁诊断或预后工具;不适用于非乌干达成人严重发热住院人群。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Severe tuberculosis (TB) is a major cause of critical illness and death in people living with HIV (PLWH) worldwide. Despite this, the immunopathology of severe HIV-associated TB (HIV/TB) is poorly understood. We aimed to identify an immunopathologic signature of severe HIV/TB in sub-Saharan Africa.

DESIGN AND SETTING: We analyzed proteomic data from two prospective observational cohorts of adults hospitalized with severe undifferentiated infection in Uganda: an urban discovery cohort (Entebbe, n = 241) and a rural validation cohort (Tororo, n = 253).

PATIENTS: Adults (age ≥ 18 yr) hospitalized with severe febrile illness.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Across both cohorts, severe HIV/TB was common, affecting 18% of participants in the discovery cohort and 21% in the validation cohort. Overall mortality was significant (30-d mortality of 22% in the discovery cohort and 60-d mortality of 26% in the validation cohort). Participants were stratified into three HIV/TB phenotypes: HIV-negative without TB, PLWH without TB, and PLWH with microbiologically diagnosed TB. We applied ordinal random forest models in the discovery cohort as a supervised feature-selection approach to identify proteins associated with progressive HIV/TB phenotype. In both cohorts, PLWH with microbiologically diagnosed TB were at highest risk of critical illness and death (30-d mortality of 42% in the discovery cohort and 60-d mortality of 52% in the validation cohort). An eight-protein signature reliably distinguished this phenotype, reflecting mediators of macrophage/dendritic cell activation (lysosome-associated membrane glycoprotein 3), natural killer cell and T-cell stimulation and cytotoxicity (cluster of differentiation 70, class I-restricted T-cell-associated molecule), B-cell activation (immunoglobulin lambda constant 2), protease-mediated tissue injury (protease, serine 2 [trypsin-2]), dysregulated coagulation (serpin peptidase inhibitor, clade A [alpha-1 antitrypsin], member 5), extracellular matrix remodeling (epidermal growth factor-containing fibulin-like extracellular matrix protein 1), and growth hormone/insulin-like growth factor axis dysregulation (insulin-like growth factor binding protein 3).

CONCLUSIONS: We identified an immunologic signature of severe HIV/TB defined by mediators of macrophage/dendritic cell and cytotoxic lymphocyte activation, extracellular matrix remodeling, and dysregulated coagulation. These findings offer new insight into HIV/TB pathobiology and highlight potential targets for host-directed therapies in this high-risk population.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Ross JE, Tomoiaga AS, Owor N, et al. Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis From Uganda. Crit Care Explor. 2026. PMID: 42645154. doi:10.1097/CCE.0000000000001439

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。